A detailed history of Gamma Investing LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Gamma Investing LLC holds 2,846 shares of EXAS stock, worth $150,581. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,846
Previous 1,362 108.96%
Holding current value
$150,581
Previous $57.5 Million 236.9%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$42.43 - $70.83 $62,966 - $105,111
1,484 Added 108.96%
2,846 $194 Million
Q2 2024

Jul 02, 2024

BUY
$41.33 - $74.26 $18,350 - $32,971
444 Added 48.37%
1,362 $57.5 Million
Q1 2024

Apr 05, 2024

SELL
$56.27 - $73.77 $11,647 - $15,270
-207 Reduced 18.4%
918 $63.4 Million
Q4 2023

Feb 01, 2024

BUY
$59.06 - $75.72 $66,442 - $85,185
1,125 New
1,125 $73.6 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.36B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.